Andrea Endimiani, MD, PhD, professor at the Institute for Infectious Diseases at the University of Bern, Switzerland, discusses how scientists can neutralize the mcr-1 gene.
Interview Transcript (slightly modified for readability)
“This is a very difficult question. At the moment we don’t have anything but [I believe] that in [the] future we will be able to create systems like the CRISPR/Cas9 system to neutralize the genetic production of this [mcr-1] gene. But at the moment, we are unable to neutralize the mechanism of resistance.
[In the future], we will [probably] find new drugs to bypass, to overcome, these system, but at the moment I will say that we don’t have a clear answer.”
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512